The presence of brown liquid was found in some vials instead of white or almost white powder, indicating a quality defect of the product and possible impact on the safety of its use. Potential effects: lack of therapeutic efficacy, complications after intravenous or intramuscular administration, and unpredictable adverse reactions.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 0710624, check the batch number on the packaging and return the packs to a pharmacy; if the product has been used, consult a doctor.
Withdrawal of batch 0710624 of Cefazolin TZF 1 g from the market throughout the country, prohibition of placing this batch on the market, granting the decision immediate enforceability, and obliging t...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related